EG7 publishes prospectus in connection with the listing change to Nasdaq Stockholm
Enad Global 7 AB (publ) (the "Company") announced on 12 June 2024 that Nasdaq Stockholm's listing committee had approved the Company's application for admission to trading of the Company's shares on Nasdaq Stockholm (the "Listing Change"). The Company has prepared a prospectus in connection with the Listing Change, which today has been approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) (the ''SFSA'') (the "Prospectus"). The Prospectus, including an English translation thereof, is available on the Company's website and the Swedish version of the Prospectus will, within a few days, be available on the SFSA's website.
Publication of the Prospectus
For complete information about the Listing Change, reference is made to the Prospectus that has been prepared by the Company and made available on the Company's website, see link. The Prospectus will also be available in Swedish on SFSA’s website (www.fi.se/sv/vara-register/prospektregistret/) within a few days.
The Prospectus has been prepared as a simplified prospectus in accordance with Article 14 of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC, as amended (the "Prospectus Regulation"). The SFSA, as the Swedish national competent authority, has approved the Prospectus in accordance with Article 20 of the Prospectus Regulation. The SFSA only approves the Prospectus as meeting the standards of completeness, comprehensibility and consistency imposed by the Prospectus Regulation. The approval should not be considered as an endorsement of the Company or of the securities described in the Prospectus. The SFSA does not guarantee the accuracy or completeness of the factual information contained in the Prospectus. Each investor is advised to make its own assessment of whether it is appropriate to invest in the Company's shares.
The Listing Change is not combined with any offering of shares. The Company's shares will continue to trade under the ticker EG7. The Company's shareholders are not required to undertake any actions due to the Listing Change.
Timetable
First day of trading on Nasdaq Stockholm is scheduled for 17 June 2024 and last day of trading on Nasdaq First North Growth Market is scheduled for 14 June 2024.
Advisers
Baker McKenzie is the Company's legal adviser in relation to the Listing Change.